Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Pancreatic cancer

This PrimeView highlights the interplay between genetic mutations, signalling pathway aberrations, microenvironmental disturbances and metabolic reprogramming that underlie the development of pancreatic cancer.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pancreatic cancer. Nat Rev Dis Primers 2, 16023 (2016).

Download citation


Quick links